Envarsus XL Immunosuppression Following Liver Transplantation

Clinical trial NCT03828058 · COMPLETED

Trial details

NCT number: NCT03828058
Sponsor: Methodist Healthcare - Memphis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recipients of Liver Transplant

Start date: 2019-04-01
Primary completion: 2020-12-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.